Willis Towers Watson Investing Cash Flow decreased by 220.7% to -$840.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 900.0%, from -$84.00M to -$840.00M. Over 2 years (FY 2022 to FY 2024), Investing Cash Flow shows an upward trend with a 20.2% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.21B | $74.00M | -$55.00M | -$77.00M | -$115.00M | -$61.00M | -$974.00M | $0.00 | -$55.00M | -$74.00M | -$84.00M | -$72.00M | $480.00M | -$84.00M | $696.00M | -$840.00M |
| QoQ Change | — | -96.7% | -174.3% | -40.0% | -49.4% | +47.0% | <-999% | +100.0% | — | -34.5% | -13.5% | +14.3% | +766.7% | -117.5% | +928.6% | -220.7% |
| YoY Change | — | — | — | — | -105.2% | -182.4% | <-999% | +100.0% | +52.2% | -21.3% | +91.4% | — | +972.7% | -13.5% | +928.6% | -900.0% |